Relay Therapeutics Inc. Common Stock vs Vivmark Residential Common Shares of Beneficial Interest — how do they compare? Relay Therapeutics Inc. Common Stock trades at $17.46 (market cap $3.82B), while Vivmark Residential Common Shares of Beneficial Interest trades at $60.01 (market cap $46.41B). The key difference: Vivmark Residential Common Shares of Beneficial Interest is far larger — about 12.1× Relay Therapeutics Inc. Common Stock's market cap, and Vivmark Residential Common Shares of Beneficial Interest pays a 4.68% dividend while Relay Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Relay Therapeutics Inc. Common Stock for 0 Days and Vivmark Residential Common Shares of Beneficial Interest for 0 Days on average.
| RLAY | VMRK | |
|---|---|---|
Market Cap | $3.82B | $46.41B |
Volume | 4,332,079 | 6,584,008 |
Sector | Health | Real Estate |
52-Week High | $20.75 | $70.15 |
52-Week Low | $6.03 | $57.98 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $2.93B | $55.52B |
Dividend Yield | — | 4.68% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →Vivmark Residential is a residential real estate investment trust that owns and operates apartment communities in U.S. markets. Its portfolio includes apartment homes and development projects.
Read more on VMRK →